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Epstein-Barr virus (EBV) replicates in a latent or a lytic 
way in the infected organism, depending on the type and 
level of differentiation of the host cell. The switch 
between latency and lytic replication was previously 
shown, for Burkitt's lymphoma cell lines, to depend on 
the viral BZLF1 gene product. Protein-DNA assays 
were used to identify the cis-acting elements that 
represent the link between regulating signal transduction 
pathways and the viral cascade of gene expression. 
Specific binding of proteins to several sites of the BZLF1 
promoter during latency was shown. Induction of the 
lytic cycle by stimulation with 12-O-tetradecanoyl- 
phorbol 13-acetate abolished the binding of these 
proteins to the distal promoter (positions -227 to 
-551), suggesting a functional role for the down- 
regulation of promoter activity during latency. Computer 
analysis identified a multiply repeated sequence motif, 
HI, in this region and exonuclease III footprints 
confirmed that these sites act as specific protein 
recognition sites. Using a set of reporter plasmids we 
were able to demonstrate a negative regulatory effect of 
the HI motif in some B lymphoid cell lines, in contrast 
to epithelial HeLa cells. The HI silencer elements are 
different from other silencer elements described so far in 
respect of their sequence and protein-binding pattern 
during the activation of BZLF1. 
Introduction 
Cell type-specific regulation of latency and productive 
lytic replication is important for the lifelong persistence 
of Epstein-Barr virus (EBV) after primary infection. A 
small proportion of lymphocytes from healthy donors 
contain latently replicating EBV genomes. However, the 
cell cycle-independent replication of viral DNA and 
death of the infected cell, as a consequence of a lytic cycle 
of virus replication, is a rare event. In epithelial tissues 
of the uterine cervix, parotid gland and tongue (Wolf 
et al., 1984; Sixbey et al., 1986; Greenspan et al., 1985; 
Becker et al., 1991; Young et al., 1991), the virus 
replicates and consequently l ses the host cell. The 
product of the viral reading frame BZLFt (Z'ta, EB1, 
ZEBRA) disrupts latency in Burkitt's lymphoma (BL) 
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cells and leads to viral replication in distinct cell types 
(Countryman et al., 1987; Bogedain et al., 1994). Z'ta 
trans-activates a eries of homologous and heterologous 
early viral promoters (Chavrier et al., 1989; Chevallier- 
Greco et al., 1986, 1989; Cox et al., 1990; Kenney et al., 
1989a, b; Lieberman et al., 1990; Rooney et al., 1989) 
and the other immediate arly genes BRLF1 (Chevallier- 
Greco et al., 1989) and BI'LF14 (Marschall et al., 1991), 
as well as the BZLF1 promoter itself (Urier et al., 1989; 
Flemington & Speck, 1990b). Hence Z'ta has a pivotal 
role in the transition from latency to lytic replication. 
Control of transcriptional ctivity by positively as well as 
negatively acting elements has been shown (Flemington 
& Speck, 1990a; Montalvo et al., 1991). In order to 
identify cis-acting elements that mediate the control of ~ 
BZLF1 gene induction by the host, we employed DNA 
binding assays with protein extracts from cells that were 
latently infected and from cells permitting lytic repli- 
cation of EBV. We identified elements that changed 
their pattern of protein binding during gene activation. 
These elements, with a common sequence motif, desig- 
nated HI, were repeated five times (~, fl, ~, 6 and e) 
within the promoter egion of the BZLF1 gene. Site- 
directed mutagenesis and transfection assays with re- 
porter constructs demonstrated their functional impor- 
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tance for down-regulation of BZLF1 during latent 
infection. 
Methods 
Cell lines and transfection assays. For transfection assays we used the 
lymphoid EBV-negative BL cell line B JAB, the EBV-positive BL cell 
line Raji, two lymphoid cell lines (LCL), established by spontaneous 
outgrowth (Ru-LCL and Em-LCL) and epithehal HeLa cells. Trans- 
fection of lymphoid cells was achieved by electroporation with a Bio- 
Rad Gene Pulser. Cells (2 x 107) were collected by centrifugation at 
1000g at room temperature~ washed once and resuspended in 
400 lal PBS. The cells were mixed with 100 lal of DNA solution (50 lag 
of plasmid DNA in PBS) and incubated for 10rain at room 
temperature. The cells were treated with a pulse of 250 V/960 laF, 
incubated for another 10rain at room temperature and finally 
resuspended in 5 ml RPMI with 10 % fetal calf serum. After 3 to 5 days, 
the culture medium was tested for the presence of the reporter protein 
hepatitis B virus surface antigen (HBsAg; Marschall et al., 1989). The 
epithelial cell line HeLa was transfected by calcium phosphate 
precipitation as described earlier (Marschall et al., 1989). Promoter 
activities were expressed as percentage activity (the average of at least 
three independent experiments) in relation to a control construct which 
did not contain EBV inserts. 
Recombinantplasmids andoligonucleotides. The recombinant plasmid 
pEBZ contains the complete promoter egion of BZLFI (Baer et al., 
1984; Skate & Strominger, 1980), from the BamHl site at position 
-551 to the NaeI site at position +13 (relative to the start site of 
transcription). The plasmid was constructed by inserting the 564 bp 
BamHI-NaeI fragment into pUC18 BamHIHincII sites. The pEBZ 
EBV insert was subcloned further, in three fragments, for bandshift 
assays. The proximal 240 bp SphI-SphI fragment was cloned into the 
pUC18 SphI-SphI site, the central 120 bp SphI-BalI fragment was 
cloned into pUCI8 HincII-SphI and the distal 200 bp BalI-BamHI 
fragment into pUC18 BamH1-HincI1. This gave the constructs pZ240, 
pZl20 and pZ200 respectively (Fig. 1). The promoter egion from 
positions -551 to -227,  relative to the start site of transcription, was 
inserted upstream of the heterologous early enhancer-promoter of 
simian virus 40 (SV40), which drives the expression of HBsAg in the 
plasmid pSVHBs (Marschall et aL, 1989). The BamHI-SphI fragment 
of the promoter was treated with T4 DNA polymerase and cloned into 
the EcoRI site of pSVHBs, which had been blunt-ended with the 
Klenow fragment of DNA polymerase, to give pSSVHBs. 
Point mutations were introduced into the BZLF1 promoter egion 
using modifications of the PCR techniques reviewed by Higuchi (1990). 
The sites targeted for mutagenesis were the HI c~, fl and 7 sequence 
motifs, identified in the promoter egion using the GCG software 
package (Devereux et aL, 1984). The sequences of each of the five 
motifs are shown in Fig. 2 (a). The mutations (indicated in bold), which 
effectively inactivate individual motifs from the promoter, resulted in a 
sequence of 5' TAAGCTTG 3" for the HI ~ element, 5" CAAGATTG 3" 
for HI fl and 5' CAAGCTTG 3" for HI ?. The PCR-mutagenesis 
products, designated ~*, fl* and 7', were cut with the restriction 
BamHI Bali S~hI NaeI 
I I "1  
I I I I 
pZ200 pZ120 pZ240 + 1 
Fig. 1. The location and arrangement of the three BZLF1 promoter 
fragments and the restriction sites used to excise them. 
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Fig. 2. (a) Sequence of the different HI elements and the HI consensus 
sequence. (b) Schematic representation of the BZLF1 promoter, 
showing the H1 motifs that are functional (circles) and non-functional 
owing to mutation (crosses). The plasmid vectors that include the 
various mutations are indicated. 
enzymes SphI and AvaI (for ~*, fl* and ~* +fl*) or Sphl and NdeI (for 
?*). They were then cloned into the recombinant plasmid 
pZAA val/NdeI at the SphI and A vaI, or NdeI sites respectively, toplace 
the original sequences of the proximal part of the promoter next to the 
mutated elements. The pZAAvaI/NdeI plasmid is identical to the pEBZ 
construct except that the AvaI and NdeI sites have been deleted. 
Finally, SstI-SphI fragments were purified, the SphI site was blunt- 
ended with T4 DNA polymerase, and subcloned into the plasmid 
pSVHBs at SstI and SmaI sites upstream of the SV40 enhancer- 
promoter. The resulting constructs, pSSVHBs~*, pSSVHBsfl*, 
pSSVHBsy* and pSSVHBsc~* +fl*, contained one or two defective HI 
motifs (Fig. 2b). All recombinant reporter plasmids were sequenced 
with an Applied Biosystems automatic sequencer. 
The HI 6 sequence motif was used as a probe in several experiments. 
The motif was incorporated into the central region of a double- 
stranded oligonucleotide, oligo-Z120HI. This oligonucleotide was 
created by annealing two complementary single-stranded sequences, 
5" GATCCACTAGAGTCCATGACAGAGGATTTGAATCTGG-  
ACTCG 3' and 5' GATCCGAGTCCAGATTCAAATCCTCTGTC- 
ATGGACTCTAGTG Y, both of which contain 5'-terminal BamHI 
sites. They were purified by PAGE, denatured for l0 rain at 95 °C and 
annealed in 10 mM-Tri~HC1 pH 8'0, 1 mM-EDTA and 150 Mm-NaCI 
at room temperature. The resulting double-stranded oligonucleotide 
has Y-protruding BamHI ends. It was purified by gel electrophoresis 
and end-labelled with [~-3~P]ATP. 
Labelling of DNA fragments and oligonucleotides. For band shift 
assays, the subcloned DNA fragments were excised from the re- 
combinant plasmids with the restriction enzymes BamHI and HindIII, 
purified by agarose gel electrophoresis and end-labelled with 
[7-32P]ATP and T4 polynucleotide kinase (5' end-labelling kit, 
Boehringer Mannheim). For footprint assays the recombinant plasmids 
were linearized at one restriction site, dephosphorylated with calf 
intestinal phosphatase and end-labelled with [7-32P]ATP. The T4 
polynucleotide kinase was then inactivated by heat and the insert was 
excised with a second restriction enzyme, to yield an asymmetrically 
Y-end-labelled fragment, which was then purified by agarose gel 
electrophoresis. 
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Nuclear extracts. These were prepared by a modification of the 
procedure described by Dignam et al. (1983). Cells (108) were harvested 
by centrifugation (600 g for 10 min at 4 °C), washed twice with PBS, 
resuspended in 5 packed-cell volumes of buffer I (10 mM-HEPES, 
1 mM-MgC12, 10 mM-KC1, 0"5 mM-DTT, 0.5 mM-PMSF pH 7"9) and 
incubated on ice for 5 rain. Thereafter the nuclei were prepared by a 
few strokes with an all-glass Dounce homogenizer, monitored by 
microscopy. The nuclei were washed t ree times in buffer I (100 g for 
10 min at 4 °C), the pellet was resuspended in 300 ~tl buffer II (20 mM- 
HEPES, 25% glycerol, 420 mM-NaC1, 1-5 mM-MgCI~, 0.5 mM-PMSF, 
0-5mM-DTT) and the proteins eluted for 30 ain on ice. The 
supernatant was clarified by centrifugation (25000 g for 3  min at 4 °C) 
and aliquots were stored at -80 °C. Further purification and 
fractionation ofthe protein extracts was achieved by chromatography. 
DNA-binding proteins were enriched on a heparin-agarose column 
(Sigma) and fractionated further on an ion-exchange column (S 
Sepharose HP, Pharmacia). 
DNA-protein binding assays. Frozen nuclear protein extracts were 
diluted with binding buffer without NaC1 (50 mM-HEPES pH 7.9, 
1 mM-EDTA, 1.5 mM-MgC12, 5 mM-DTT, 10% glycerol) to the op- 
timum NaCI concentration f 200 mM. In band shift assays, 2 to 5 ~tg 
of nuclear proteins were preincubated for 30rain, in binding buffer 
containing 150 mM-NaCI to a volume of24 ~tl, with 2-0 ~tg of dAdT to 
reduce non-specific binding of proteins and with increasing concentra- 
tions of specific ompetitor DNA. Next, 1 ng (approximately 8 fmol) 
of 3Zp-labelled probe was added and incubated for 15 min. After 
electrophoresis in a 4 % polyacrylamide gel, the DNA was visualized by 
autoradiography. For footprint assays 2 x 104 c.p.m. (Cerenkov counts) 
of asymmetrically 32p-end-labelled DNA was incubated with increasing 
concentrations of protein, to a volume of 38 ~tl, using the same 
conditions as for gel retardation. Then 2 ~tl of 0.1 M-MgCI~ and 175 
units of exonuclease III (Boehringer Mannheim) were added and 
incubated for 10min at 37 °C so that the DNA fragments were digested 
unidirectionally, starting at their 3' ends. Proteins bound to DNA 
caused the enzyme to stop, yielding DNA fragments with distinct sizes 
relative to the 5' label (Hennighausen & Lubon, 1987). The reaction 
was stopped with 150 pl of 0.5 % Sarcosyl, 10 mM-EDTA, 0.4 M-NaC1, 
2.5 ~tg/pl glycogen, extracted once with phenol-chloroform-isoamyl 
alcohol, precipitated with ethanol and separated by electrophoresis in 
a 6% sequencing gel in 0.5 × TBE. 
Results 
Proteins bind specifically during latent replication to the 
distal promoter of BZLF1 
Control  of  BZLF 1 gene transcription is one possible way 
to control viral replication. It has been shown earlier that 
negative (Montalvo et al., 1991) as well as positive 
(F lemington & Speck, 1990a, b) regulatory elements 
control the activity of this gene. We compared binding of 
protein in the regulatory region of BZLF1 in latently 
infected cells and cells permissive for lytic replication. To 
visualize specific binding of regulatory factors, the region 
from -551  to +13, relative to the start of the 
transcription, was subcloned in three fragments which 
were designated Z200 (distal region), Z120 (central 
region) and Z240 (most proximal region), according to 
their length in bp, (Fig. 1). Fig. 3 shows the formation 
of several p ro te in -DNA complexes after incubation of 
these promoter fragments with crude nuclear extracts. 
EBV-negative B JAB cells and EBV-positive, latently- 
infected Raji cells were compared to 12-O-tetradecanoyl- 
phorbol  13-acetate (TPA)-stimulated Raji cells, which 
are a model for cell types supporting the lytic replication 
of EBV. In latently infected Raji cells a specific complex 
is visible with fragments Z120 and Z200 (lanes 5 and 12). 
With extracts of EBV-negative B JAB cells only a very 
faint specific complex is visible with both fragments 
(lanes 3 and 10). Competit ion of protein binding with 
pUC18 DNA AluI fragments did not weaken the binding 
of these proteins to the labelled DNA.  When binding was 
competed specifically with the unlabelled homologous 
fragment, the indicated specific bands disappeared (lanes 
4 and 11). The specific complexes with fragments Z120 
and Z200 did not form with protein extracts from TPA- 
treated cells (lanes 7 and 14). The most proximal 
fragment Z240 also showed specific p ro te in -DNA 
complexes but these complexes were unaltered after TPA 
treatment (lanes 15 to 20). With all promoter fragments, 
addit ional non-specific p ro te in -DNA complexes were 
visible that were insensitive to TPA treatment (compare 
lane 4 with lane 6 and lane 11 with lane 13). These results 
demonstrate specific binding of cellular factors during 
latent, but not during lytic, replication in the distal 
(a) Z 120 Z200 Z240 
c BJAB Raji c BJAB Raji BJAB Raji 
TPA - - - + + + + . . . .  + + 
pUCI8 - + + - + - + + - + + - + - + 
Z120 +-  + - + - 
Z200 + - + +-  
Z240 + - + +-  
1 2 3 4 5 6 7 8 91011121314 151617181920 
Fig. 3. Band shift experiment with the distal region of the BZLF1 
promoter and nuclear extracts from EBV-negative B JAB cells and 
EBV-positive Raji cells. Specific protein-DNA complexes (lanes 5 and 
12) are indicated by arrowheads. When extracts from TPA-stimulated 
cells were used these complexes disappeared (lanes 7 and 14). Use of 
nuclear extracts from unstimulated or TPA-stimulated Raji cells, as 
well as specific (Z120 and Z200) or non-specific (pUC18) competition, 
is indicated above the respective lanes. The pattern of protein complexes 
was not altered after TPA stimulation with fragment Z240 (lanes 15 to 
20). 
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CCAGCCACTTGACCCGGCCCCCGCAGTAACCCCCGAGGCAAGTCATCTGTTGGAGGACCC 
10372t  . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + 
TGATGAAGAAACCAGTCAGGCCGTGAAGGCCCTAAGGGAGATGGCTGACACTGTTATTCC 
103661 . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + 
-465  ACTACTTCTTTGGTCAGTCCGGCACTTCCGGGATTCCCTCTACCGACTGTGACAATAAGG 
CCAGAAGGAGGAAGCAGCCATATGTGC~ACAGATG(IACCTGAGCCACCCGCCCCCTCGTGG 
I0360t  . . . . . . . . .  + . . . . . . . . .  + . . . . . . .  b = ¥ ~ = = = f  . . . .  + . . . . . . . . .  + . . . . . . . . .  + 
-405 GGTCTTCCTCCTTCGT~TATAC~CCTGTCTACCTGGACTCGGTGGGCGGGGGAGCACC 
CCATTTGGACGAACTGACCACAACACTAGAGTCCATCxACAGAGGA~TTGAATCTGGACTC 
103541 . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . .  t=¥=: : := '____+ . . . . . . . . .  + 
-345 GGTA-AACCTGCTTGACTGGTGTTGTGATCTCAGGTACTGTCTCCTAA.ACTTAGACCTGAG 
10348t  
-285  
CCCCCTGACCCCCGAACTTAATGAAATCTTGGATACATTTCTAAATGATGAATGTCTGCT 
. . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + 
GGGGGACTGGGGGCTTGAATTACTTTAGAACCTATGTAAAGATTTACTACTTACAGACGA 
10342 t 
-225  
GCATGCCATGCATATTTCAACTGGGCTGTCTATTTTTGACACCAGCTTATTTTAGACACT 
. . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + 
CGTACGGTACGTATA/hAGTTGACCCGACAGATAAAAACTGTGGTCGAATAAAATCTGTGA 
TCTGAAAACTGCCTCCTCCTCTTTTAGAAACTATGCATGAGCCACAGGCATTGCTAATGT 
10336t  . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + 
-165 AGACTTTTGACGGAGGAGGAGAAAATCTTTGATACGTACTCGGTGTCCGTAACGATTACA 
ACCTCATAGACACACCTAAATTTAGCACGTCCCAAACCATGACATOACAGAGGA]G.'GCTGG 
10330 l  . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . .  ~=~'~'~'=t ' _  . . . .  + 
-105 TGGAGTATCTGTGTGGATTTAAATCGTGCAGGGTTTGGTACTGTAGTGTCTCCTCCGACC 
+i 
TGCCTTGGC~..TT~GGGAGATGTTAGACAGGTAACTCACTAAAC7 
103241 . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . .  
-45  ACGGAACCGAAATTTCCCCTCTACAATCTGTCCATTGAGTGATTTG< 
Fig.4.Sequen~e~theupstreamregu]at~ryregi~n~theBZLF~reading~ame.TheHIe~ementsthathavebeenidenti~edby~mputer 
analysisandconfirmedbyprotein-DNA bindingassaysaredepictedasboxes. 
promoter egion of BZLF1, indicating a functional role 
for the down-regulation f this promoter during latency. 
The site that mediates pecific binding of protein during 
latency & multiply repeated in the promoter of BZLF1 
Band shift competition experiments with the three 
subfragments showed that all three would compete for 
specific complex formation. This was in contrast to 
competition with pUC18 DNA (data not shown), 
suggesting a binding site for the protein is present on 
each of these fragments. Sequence analysis of the 
promoter egion using GCG software (Devereux et al., 
1984) detected a multiply repeated sequence. This motif, 
designated the HI element, with the consensus sequence 
5' ACAGA(T/G)G(A/G)3' was found three times in 
region Z200, once in region Z240 and once in Z120 (Fig. 
4 and Fig. 2 a). Footprint experiments were performed to 
test whether these sites were occupied by proteins in 
latently infected cells. In agreement with another eport 
(Montalvo et al., 1991), no clear footprinting was 
possible in this region using crude nuclear extracts. 
Exonuclease III footprints were therefore employed. 
These are much more sensitive than DNase I assays 
(Vogel et al., 1989) because ach bound protein molecule 
theoretically yields a positive signal. The results of the 
footprint assays are depicted in Fig. 5, in relation to the 
location of the HI sequences identified by computer 
analysis. Using increasing concentrations of protein, 
binding was detected at various distances from the 3' end 
of the DNA. On each of the fragments used in band shift 
assays, proteins bound to one HI sequence. These sites 
specifically bound proteins from unstimulated lympho- 
cytes and have been described, in part, previously 
(Flemington & Speck, 1990a, b). Indeed, the HI motif 
did function as a specific binding site, and in latently 
infected Raji cells three (~, 6 and e) of the five elements 
were bound by protein. 
To confirm that the HI elements were involved in the 
formation of TPA-sensitive protein-DNA complexes, 
protein fractions from unstimulated and TPA-stimulated 
Raji cells were tested for the ability to bind to the HI 
sequence motif using the probe oligo-Z120HI. Crude 
nuclear extracts were divided into two fractions by 
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Fig. 5. Exonuclease III footprint assay (a) with the BZLF1 promoter egion from positions -551 to + 13 and nuclear extracts from 
latently infected EBV-positive Raji cells. Boundaries of protein DNA complexes are indicated by arrowheads and the nucleotide 
positions relative to the transcriptional start site are given beside the lanes. Also included are a control without protein but with 
exonuclease (-protein) ,  a control without exonuclease ( -Exo I I I )  and a sequencing lane (A+ G). The lanes marked ExoIII are 
exonuclease digests with increasing amounts of protein. The extreme right-hand assay is a duplicate of its neighbour, using a shorter 
exposure time. (b) A diagram of the upstream regulatory region of BZLF 1. The regions between exonuclease III stops, which are bound 
by proteins, are depicted as bars. ZI, ZII and ZIII are regulatory elements described previously (Flemington & Speck, 1990a, b). 
heparin-agarose and ion exchange column chromato- 
graphy. Fig. 6 shows that in latently infected cells only 
(lanes 1 and 2) a protein in fraction I bound to the HI 
motif, but did not bind after TPA treatment (lane 3), nor 
to the larger fragment Z120 (lane 6). In fraction II 
however, there were proteins that bound to the larger 
Z120 fragment after TPA stimulation (lanes 7 and 8) but 
did not bind to the HI motif (lanes 4 and 5). 
HI elements act as negative regulatory silencer elements 
As the pattern of protein binding points towards a 
silencing mechanism during latency, we constructed 
reporter plasmids with site-specific mutations in the HI 
motif to investigate heir regulatory influence. The results 
are shown in Table 1. When the intact region from 
positions -551 to -227 was tested upstream of the 
heterologous enhancer-promoter in the EBV-negative 
B JAB cell line, a 60 % decrease in promoter activity was 
observed. In none of the other tested cell lines was a 
comparable influence detected. Each of the four muta- 
tions abolished the negative regulatory effect, suggesting 
a contribution of each of the destroyed elements to the 
silencing function in this cell line. Interestingly, muta- 
tions fl*, y* and ~* +fl* not only abolished the negative 
regulation, but increased the promoter activity from 40 
to 144% (relative to the control) in BJAB cells. Similar 
results were observed for the Raji cell line, where 
mutation of the HI elements fl, y and ~ plus fl 
reproducibly increased the promoter activity to about 
160%. Raji cells showed no repression of activity with 
the intact distal region; a mutation in the ~ HI element 
had no influence and activity remained at 100% of the 
control. With the two LCLs however, strong activation 
occurred with mutation fl* and ~*, of up to 217 % in Ru- 
LCL and up to 302% in Em-LCL. The ~* mutation 
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Oligo-Zl20HI Z120 
Fraction I II I II 
I 1 [ l ~ [ 
TPA _ _ + + + + + 
1 2 3 4 5 6 7 8 
+ 
Fig. 6. Band shift experiment showing latency-specific b nding of 
protein to the HI sequence motif, using two purified protein fractions 
(I and II). The arrow indicates the sp cific omplex of the HI motif 
oligo-Z120HI with protein in latently infected cells (lanes 1 and 2), 
which did not bind after TPA treatment (lane 3). Lanes 4 to 8 are 
controls described in the text. 
resulted in the strongest enhancement of promoter 
activity (up to 280 % in Ru-LCL and 760 % in Em-LCL) 
and there was no negative ffect of the unmutated istal 
region. These results demonstrate that the HI  elements 
are negative regulatory silencing elements under appro- 
priate conditions, depending on the indivdiual cell line 
and also confirm the presence of positive regulatory 
elements located in the promoter region between 
positions -227  and -551,  described earlier by 
Montalvo et al. (1991). In HeLa cell line, neither an effect 
of the intact distal promoter nor of the different HI  
mutations could be measured. 
Discuss ion  
We have identified a sequence motif, HI, that is repeated 
five times in the promoter egion of BZLF1 (Fig. 4). 
Band shift assays with specific oligonucleotides and 
exonuclease I I I  footprints howed that there are cellular 
proteins in latently EBV-infected lymphoid cells that 
bind to the HI  motif. In the distal region of the promoter 
(Z 120 and Z200) these sites showed loss of bound protein 
following TPA treatment, indicating a role in repression 
of the BZLF1 promoter during latency. Cloning of the 
distal promoter, from positions -551  to -227,  in front 
of the heterologous SV40 enhancer-promoter in a 
reporter plasmid and in vitro mutagenesis of individual 
HI elements showed that the HI  elements confer a 
negative regulatory influence on the downstream pro- 
moter. 
Flemington & Speck (1990a) have shown that the 
proximal region of the promoter, but not the distal 
region, contains regulatory elements that directly re- 
spond to TPA in EBV-negative cell lines and that are 
directly involved in promoter activation. However, they 
could not identify the HI  silencer elements which down- 
regulate stimulatory elements nearby. This HI  mech- 
anism is cell line-dependent and functions only very 
poorly in EBV-negative lymphoid B JAB cells and in 
EBV-positive Raji cells, and not at all in epithelial HeLa 
cells. After TPA treatment the HI  elements lose their 
negative regulatory effect. We assayed HI  function by 
inactivation of these elements without TPA stimulation 
of the cells and thereby demonstrated HI activity during 
Table 1. Regulatory activity of the promoter egion of the BZLF1 reading frame in different cell lines 
Construct* HBsAg expression (%)t 
Cell line pSVHBs pSSVHBs  pSSVHBs-~* pSSVHBs-fl* pSSVHBs-F* pSSVHBs-c~*/¢* 
BJAB 100 40 (10){ 100 (19) 144 (26) 123 (44) 122 (17) 
Raji 100 116 (7) 102 (3) 160 (10) 154 (44) 152 (35) 
LCL-Em 100 164 (57) 760 (28) 211 (26) 302 (73) 650 (6) 
LCL-Ru 100 119 (2) 280 (16) 197 (24) 217 (10) 233 (42) 
HeLa 100 92 (3) 88 (6) 98 (6) 88 (4) 96 (6) 
* The plasmids designated pSS have mutated versions f the promoter (Fig. 1). 
"~ Percentage activity in relation to the positive control plasmid pSVHBs. 
~: Figure in parentheses is the s.p.; at least hree assays were performed for each result. 
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latent infection. Furthermore, these experiments show 
that the activity of positive regulatory elements is 
controlled by the HI silencer during latency in some cell 
lines. Taking into account he results of Flemington &
Speck (1990 a), the target elements hat are suppressed by 
the HI motifs are not directly stimulated by TPA. TPA 
sensitivity concerns silencer inactivation but not in- 
duction of the positive elements, which seem to be 
regulated in a TPA-independent way. In the EBV- 
negative BJAB cell line, the presence of the intact distal 
promoter, from position -227 to -551, decreased 
activity of the SV40 enhancer-promoter to about 40 %. 
In all other cell lines tested, whether lymphoid or 
epithelial, no silencing function of the intact distal 
upstream region was observed. A likely explanation for 
this difference is the weak activity of positive control 
elements in B JAB cells, which results in a stronger 
suppression by the silencer elements. The model of a 
negative and a positive regulatory module also explains 
the results obtained in Raji cells. In these cells we could 
demonstrate binding of protein to the HI sequences (Fig. 
3), but inactivation of these sites had only a slight effect 
on the activity of a downstream promoter (Table 1) 
because the positive regulatory target elements were 
inactive. Experiments oidentify the trans-acting cellular 
proteins that interact with these positive and negative 
regulatory cis-acting elements are in progress. 
The HI elements ~, fl and 7 are different from some of 
the negative regulatory elements located in the proximal 
region of the promoter from - 227 to + 13 described by 
Flemington & Speck (1990a). They also differ from a 
48 bp silencer described by Montalvo et al. (1991). Fig. 7 
shows the HI elements ]~ and y in relation to the 48 bp 
silencer. The inverted repeat sequences on the right side 
of the 48 bp silencer are identical to the HI fl and y but 
there are two important properties of HI that 
distinguishes the two silencers. Firstly, mutation of the 
most distal HI element, e, blocks the observed silencer 
I II 
I I [ NdeI ] HI7 
• < >< 
[ SRE I 
HIfl 
Fig. 7. Schematic drawing of the distal promoter of BZLF1. The area 
containing the 48 bp silencer element described previously (Montalvo 
et al., 1991) partially overlaps with the HI elements, but they are not 
functionally identical. Regions I and II are protein-bound elements of 
the silencer egion described earlier (Montalvo et al., 1991) as are the 
inverted repeats, indicated by arrows, which are important for activity. 
SRE denotes a serum response lement overlapping region II, the right 
inverted repeat pair and one HI element. 
activity on the tested EBV promoter fragment in B JAB 
cells, Ru-LCL and Em-LCL, hence a negative regulatory 
effect is clearly demonstrated. This element is located at 
a considerable distance from the 48 bp silencer. Secondly, 
the HI mechanism does not function in HeLa cells, as 
described for the 48 bp silencer. Since our reporter 
constructs, irrespective of any HI mutations, how very 
high levels of activity in the HeLa cell line, we believe 
that this results from inactive HI silencer modules and 
active enhancer elements. Observations of different 
patterns of protein binding in this cell line are in 
accordance with this hypothesis (F. Schwarzmann, N. 
Prang, B. Reichelt, B. Rinkes, S. Haist, M. Marschall & 
H. Wolf, unpublished results). Therefore there is evi- 
dence that, in epithelial cells, lytic replication of EBV 
may be significantly influenced by non-functional HI 
elements releasing suppression ofthe enhancing modules. 
In conclusion, we have identified a new type of 
silencing sequence motif, HI, in the promoter of the 
BZLF 1 gene, which is involved in the down-regulation f 
this lytic trans-activator in latently infected lymphoid 
cells. The proximity of the HI motif to other protein 
binding regions, identified by footprinting, and to 
binding motifs for other regulatory cellular factors like 
YY1 (Seto et al., 1991), SRE (Gualberto et al., 1992; 
Treisman, 1986) and AP1 (Rauscher et al., 1988) suggests 
that the HI binding factor works through protein- 
protein interactions or by steric hindrance xerted on 
binding sites in the proximity. 
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